Skuldtech is involved in the development of new diagnostics focused on personalized medicine applications. The company has already developed prototypes dedicated to the identification of specific biomarkers. 

Due to its expertise in genomics, in gene expression, in New Generation Sequencing (NGS) technologies, in bioinformatics and biostatistics, Skuldtech is currently involved in several developments concerning personalized medicine, companion diagnostics and patient stratification tests, which will enable stratifying and segmenting patients according to “typical profiles.”
Some of these innovative healthcare solutions are being subject to clinical validation. 

Moreover, Skuldtech has developed several prototypes focused on the (early) detection of emerging pathogens, such as: Dengue, Leishmania, etc.
These innovative healthcare prototypes are being subject to clinical validation. 

The company provides also a “biomolecular techniques” kit allowing the training of several molecular biology techniques. To discover this product, please visit the Training services page. 


If you need more information, please contact our business development department
(T: +33(0)467 419 748, Email: info@skuldtech.com).